Table 1.
Low HDL | High HDL | P | |
---|---|---|---|
Gender |
21 men/16 women |
20 men/16 women |
|
Age (year) |
37 ± 11 |
45 ± 14 |
0.022 |
BMI (Kg/m2) |
24.0 ± 2.4 |
23.5 ± 3.3 |
|
Waist (cm) |
80 ± 9 |
80 ± 9 |
|
Glucose (mg/dL) |
83 ± 8 |
84 ± 8 |
|
Insulin (μU/mL) |
6.5 ± 3.1 |
4.4 ± 1.8 |
<0.001 |
HOMA index |
1.35 ± 0.67 |
0.91 ± 0.39 |
0.001 |
Triglycerides (mg/dL) |
97 ± 33 |
71 ± 34 |
0.002 |
Cholesterol (mg/dL) |
159 ± 25 |
186 ± 30 |
<0.001 |
HDL-C (mg/dL) |
34 ± 4 |
79 ± 13 |
<0.001 |
LDL-C (mg/dL) |
106 ± 22 |
93 ± 22 |
0.018 |
VLDL (mg/dL) |
19 ± 7 |
14 ± 7 |
0.001 |
TG/HDL ratio |
3.00 ± 1.32 |
0.91 ± 0.42 |
<0.001 |
Apo AI (mg/dL) |
84.8 ± 15.5 |
124.9 ± 19.4 |
<0.001 |
Apo B (mg/dL) |
75.4 ± 21.7 |
71.8 ± 17.1 |
|
Apo CII (mg/dL) |
3.1 ± 1.9 |
3.1 ± 1.5 |
|
Apo CIII (mg/dL) |
7.3 ± 3.1 |
6.7 ± 4.4 |
|
Apo E (mg/dL) |
2.1 ± 0.8 |
3.2 ± 1.2 |
<0.001 |
ALT (U/L) |
24 ± 16 |
16 ± 5 |
0.005 |
AST (U/L) |
20 ± 6 |
19 ± 3 |
|
hsCRP (mg/L) |
1.7 ± 2.0 |
2.1 ± 4.6 |
|
SAA (mg/L) |
3.2 ± 2.8 |
6.4 ± 10.5 |
|
CETP (%CE) |
13.6 ± 5.3 |
13.5 ± 4.5 |
|
PLTP (nmolPC/mL/h) |
6,247 ± 1,851 |
6,439 ± 1,617 |
|
LCAT (%CE) |
3.71 (2.48-5.02) |
2.68 (1.63-3.61) |
0.011 |
LPL (nmFFA/mL/h) |
2,403 ± 1,304 |
4,597 ± 2,616 |
<0.001 |
HL (nmFFA/mL/h) |
4,517 ± 1,622 |
3,159 ± 1,424 |
<0.001 |
Pre-beta1-HDL (ng/mL) | 11.8 ± 5.7 (n = 33) | 22.4 ± 22.5 (n = 34) | 0.008 |
ALT, Alanine aminotransferase. Apo, Apolipoprotein. AST, Aspartate aminotransferase. BMI, Body mass index. CETP, Cholesteryl ester transfer protein. HL. Hepatic lipase. HOMA, Homeostasis model assessment. LCAT, Lecithin: cholesterol acyltransferase. LPL, Lipoprotein lipase. hsCPR, C- reactive protein. SAA, Serum amyloid A. PLTP, Phospholipid transfer protein. Student t test, low HDL-C vs. high HDL-C. Data are presented as mean ± SD. P < 0.05. Pre-beta1-HDL (n = 33 low HDL-C; n = 34 high HDL-C). PLTP, HL and LPL (n = 34 low HDL-C; n = 66 high HDL-C).